Topic overview

Start with the big picture

Benzodiazepines provide a central example of how molecular structure influences drug action: their 1,4-benzodiazepine nucleus and key substituents relate to GABA_A receptor modulation, receptor affinity, CNS penetration, and duration. The topic also considers metabolism, including direct conjugation for some 3-hydroxy compounds and the formation of active metabolites from diazepam. Comparisons broaden the picture: Z-drugs share a GABA_A-related pharmacophore without the benzodiazepine skeleton, while barbiturate substitutions affect lipophilicity and onset. Other classes act through distinct targets, including serotonin, melatonin, and orexin receptors. Together, these examples offer a structure-focused introduction to the chemical and pharmacokinetic differences among anxiolytics and hypnotics.